Results 201 to 210 of about 75,701 (257)
Some of the next articles are maybe not open access.
Dystrophin: From non-ischemic cardiomyopathy to ischemic cardiomyopathy
Medical Hypotheses, 2008Dystrophin and its associated proteins form a scaffold underneath the cardiomyocyte membrane and connect the intracellular cytoskeleton to the extracellular matrix. Dystrophin localizes at the X chromosome, whose mutations might result in Duchenne muscular dystrophy, Becker muscular dystrophy and X-linked dilated cardiomyopathy.
Qiang Sun, Zheng +5 more
openaire +2 more sources
Q waves in ischemic cardiomyopathy
The International Journal of Cardiovascular Imaging, 2021Q waves may be observed in the absence of non-viable tissue. However, their scintigraphic translation in patients with ischemic cardiomyopathy (ICM) has not been properly assessed. This study sought to establish the determinants of Q waves in the absence of non-viable tissue and the diagnostic accuracy in this population.
Eduard Ródenas-Alesina +7 more
openaire +2 more sources
Relief of Ischemia in Ischemic Cardiomyopathy
Current Cardiology Reports, 2021Ischemic heart disease is among the most common causes of morbidity and mortality worldwide. In its stable manifestation, obstructing coronary artery stenoses prevent myocardial blood flow from matching metabolic needs of the heart under exercise conditions, which manifests clinically as dyspnea or chest pain.
Francesco, Moroni +2 more
openaire +2 more sources
Lipomatous metaplasia in ischemic cardiomyopathy
Journal of Cardiovascular Medicine, 2009Lipomatous metaplasia is characterized by substitution of muscle fibers with adipose tissue in the context of a myocardial scar. Cardiac magnetic resonance is an accurate cardiac imaging technique with high tissue spatial resolution that can easily characterize scar tissue, adipose tissue and lipomatous metaplasia.
DI BELLA, Gianluca +7 more
openaire +2 more sources
Therapy of Ischemic Cardiomyopathy with Pentoxifylline
Angiology, 1990Abnormal blood rheology is a known characteristic of coronary artery disease. The authors evaluated the effects of pentoxifylline on the exercise capacity ejection fraction and symptoms of 9 patients with ischemic cardiomyopathy. All patients had signs and symptoms of left ventricular dysfunction.
J C, Barnett, R C, Touchon
openaire +2 more sources
Surgical remodeling in ischemic cardiomyopathy
Current Treatment Options in Cardiovascular Medicine, 2003Ischemic cardiomyopathy has a very poor prognosis, despite significant advances in pharmacologic therapy in the past decade. Orthotopic heart transplantation is an option for only a small minority of patients. Due to donor shortage and a finite outcome after transplant, nontransplant surgical intervention should be intensively investigated.
James O., O'Neill, Randall C., Starling
openaire +2 more sources
The Arrhythmogenic Substrate in Ischemic and Non-ischemic Cardiomyopathies
2001For the mechanistic study of arrhythmias in clinical practice the terms “arrhythmogenic substrate”, “initiating factor” and “modulating factors” have been introduced.1 We define the substrate as “a pre-existing condition that forms a prerequisite for the induction of an arrhythmia”.
Coronel, R. +4 more
openaire +2 more sources
Gender Differences in Ischemic Cardiomyopathy
Current Atherosclerosis Reports, 2018Cardiovascular disease remains the leading cause of death among women globally, majority of which are due to ischemic heart disease. Despite the recent advances in the overall management of CVD, there are unique challenges in the diagnosis and management of women as well as poorer outcomes.Women with ischemic cardiomyopathy experience significant ...
Laura, Divoky +2 more
openaire +2 more sources
Ventricular reconstruction for ischemic cardiomyopathy
The Annals of Thoracic Surgery, 2003Left ventricular surgical reconstruction has been advocated for patients with coronary artery disease, prior myocardial infarction, and poor left ventricular function. The objective of the approach is to resect or exclude all akinetic or dyskinetic nonfunctioning portions of the ventricular cavity and to restore the left ventricle size and shape toward
Lynda L, Mickleborough +4 more
openaire +2 more sources
Ischemic cardiomyopathy: Pathophysiologic mechanisms
Progress in Cardiovascular Diseases, 1990SCHEMIC cardiomyopathy is an anatomic condition emanating from a sustained imbalance between oxygen supply and demand of the heart that, in turn, leads to myocyte loss with resultant myocardial scarring and ventricular failure. Cell loss can occur as a result of focal narrowing or occlusion of the main coronary arteries by atherosclerosis, spasm of the
P, Anversa, E H, Sonnenblick
openaire +2 more sources